Nautilus Biotechnology (NAUT) Cash from Investing Activities (QoQ) (2020 - 2026)
Nautilus Biotechnology (NAUT) Cash from Investing Activities (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Nautilus Biotechnology | 212.11 Mn | 116.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,708.51% |
| Dec 31, 2025 | 74.12% |
| Sep 30, 2025 | -96.88% |
| Jun 30, 2025 | -25.82% |
| Mar 31, 2025 | -47.42% |
| Dec 31, 2024 | 594.55% |
| Sep 30, 2024 | -152.49% |
| Jun 30, 2024 | -36.05% |
| Mar 31, 2024 | 154.44% |
| Dec 31, 2023 | -414.03% |
| Sep 30, 2023 | 679.82% |
| Jun 30, 2023 | 83.29% |
| Mar 31, 2023 | 78.93% |
| Dec 31, 2022 | -436.34% |
| Sep 30, 2022 | -134.05% |
| Jun 30, 2022 | 131.04% |
| Mar 31, 2022 | 150.36% |
| Dec 31, 2021 | 107.22% |
| Sep 30, 2021 | 0.69% |
| Jun 30, 2021 | -459.58% |